Swissray nears sale of x-ray assets

Article

The first company to introduce a digital radiography system in the U.S. may soon be sold. Swissray International announced Sept. 24 the signing of a nonbinding letter of intent with a U.S.-based private equity firm to acquire all the outstanding shares

The first company to introduce a digital radiography system in the U.S. may soon be sold. Swissray International announced Sept. 24 the signing of a nonbinding letter of intent with a U.S.-based private equity firm to acquire all the outstanding shares of Swissray's capital stock. Swissray has installed its CCD-based ddR (direct digital radiography) systems in the U.S., Europe, the Middle East, and Asia. The company began shopping for a buyer in February at the behest of its major shareholder Hillcrest Avenue, which owns more than 52 million of the company's 91 million common shares. The letter provides for a limited exclusivity period in which to conduct due diligence, to agree on the form and terms of the transaction, and to enter into a definitive contract. Neither Swissray nor its major stockholders may pursue other potential buyers during this time. If the letter of intent is terminated, sale to another buyer within six months will require Swissray to pay a penalty.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.